fbpx

MedTech

MED-CANN

BY MED-TECH WORLD

Innovation across the whole of healthcare

The cannabis industry is one that has traditionally been fraught with regulatory hurdles, gray areas and ethical pot holes. It is refreshing to finally reap the results of long discussions and negotiations between all those involved and see this industry flourish across countries, as more and more countries lift their restrictions and new businesses move into play.

From seed-to-sale tracking to personal, patient-based medical products, the convergence of these two spheres promises great things for the future of medical cannabis, something we’re sure many of the investors attending our summits will be keen to explore.

This same shift is also alluring for the hope it brings to patients suffering from chronic illnesses, something which we have been very keen to explore in our past editions. Patients too deserve to have their thoughts heards and wishes served.

SiGMA, being a pioneer in the Medical-Cannabis Conference Industry was very adamant to continue hosting this vertical, in parallel with Malta’s perseverance to build its own flourishing Medical Cannabis Industry and as a result, will continue to host this during the Malta Week two-day summit, with a separate stage solely dedicated to medical cannabis and other related topics, including the rise of psychedelics.

Partners

Having supported the Med-Tech event since 2019 both Matt Lawson and I regard this as the premier European conference and a World leader.  The support at Government level and the outstanding organisation by SIGMA set the event apart. 

Medicinal Cannabis and Med-Tech are at the forefront of patient access, professional adoption and delivery mechanism development. We view the conference as the opportunity to meet and discuss industry issues with medical professionals, government ministers, leaders in the field of medical technology and a global network of friends.  This is an event that is first in the calendar and we urge those in the industry to attend.

CISW Summit was first held in 2020, a grand-scale virtual summit that brings together a team of leading cannabis experts, scientists, university professors, researchers, entrepreneurs, investors, and developers from Thailand and around the world. Partnering up with Med-Cann World Summit by SiGMA was the next most logical thing to do. We look forward to connecting Thailand with the rest of the world through the upcoming Malta November Med-Cann Summit, as we seek to continue developing the medical cannabis industry in Asia and beyond.

3rd CISW SUMMIT WORLD joining MED-CANN SUMMIT!

Cannabis Investment Summit World (CISW) is currently one of the biggest cannabis and hemp events in Asia.Led by Mr. Jacky Ong, President of CISW Holding Group, CISW will showcase how Thailand is proving to be one of the world’s emerging medical cannabis hubs.

Gathering an audience from all over the world for everyone who is interested in all aspects of the medical cannabis and hemp industry, including research and development, investment opportunities, and the  science behind therapeutics. The summit aims to be a timely and informative conference. Our dedicated team aims to attract leaders and investors from both public and private sectors around the world.

Main Sponsors; 88 Cannatek

https://www.ciswinternational.com/cisw-summit

 


Thursday 17th November 2022 (Amphitheater)

10:00-10:10

Introduction to Med-Cann World

Dr Dylan Attard
10:13-10:33

Access to Medicinal Cannabis in Europe. The barriers, challenges and solutions.

MATTHEW LAWSON, STEPHEN OLIVER (Canna Consultants)
10:36-11:06

Cannabinoids in epilepsy: friend or foe?

GIUSEPPE DI GIOVANNI
11:09-11:56

Challenges for the Medical Cannabis Industry in Europe

12:00-12:45

Developing a cannabinoid-based formulation for the treatment of cancer

Prof. Hinanit Koltai, PhD

Friday 18th November 2022 (Amphitheater)

13:00-13:45

Medical Cannabis at the intersection of biotech, pharma and big data - Building a winning portfolio in the emerging medical cannabis field

LILAC MANDELES
13:48-14:03

Export and Import through the European Union. 

14:05-14:50

Christopher Tasker; Master of Cannabinoid Research 

Chris Tasker
14:53-15:33

The Patient’s Choice: Private, Publicly Funded or Self Medication. 

MATTHEW LAWSON, STEPHEN OLIVER, Chris Tasker, MARK GLEDHILL, Kyle Esplin
16:08-16:23

Bioburden: Key considerations for the cannabis industry

Dr. Noelia Holgado Sánchez

speakers

KYLE ESPLIN

PROF. HINANIT KOLTAI
PhD

JACKY ONG

ASSOC. PROF .DR. THAVATCHAI KAMOLTHAM

DR. NOELIA HOLGADO SáNCHEZ

CHRIS TASKER

ALEXANDR FLOKA

YONA CYMERMAN

CHRISTOPHER MORRIS

STEPHAN GATH

LILAC MANDELES

MAX KANEVSKIY

GOLAN BITTON

DR AIMON KOPERA

MARION ZAMMIT

CHRISTIAN DUCHOW

THOMAS GRIMA

RICHARD SANDERS

DR SANDRA CARRILLO

GIUSEPPE DI GIOVANNI

MARK GLEDHILL

MATTHEW LAWSON

STEPHEN OLIVER

DR ANDREW AGIUS

ALEX AGIUS SALIBA

HON. DEO DEBATTISTA

PORNPRASIT SIBUNRUANG

ALEX LATYSHEV

Companies who trusted us